Prestige Consumer Healthcare Inc.
As of Oct 16, 2026 close
- Market cap
- $2.34B
- P/E (TTM)
- 13.62
- Forward P/E
- 17.06
- Dividend yield
- -
- 52-week range
- $42.62$71.07
- Volume (live)
- -
- Avg. volume (3M)
- 581.19K
Prestige Consumer Healthcare (PBH) Stock Price & Financial Analysis
Prestige Consumer Healthcare Stock Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
| Day's Range | $49.28 - $50.27 |
|---|---|
| 52-Week High | $71.07 |
| 52-Week Low | $42.62 |
| Open | $49.48 |
| Volume (last close) | 580.63K |
| Average Volume (3M) | 581.19K |
| Revenue (TTM) | 1.10B |
|---|---|
| Net Income (TTM) | 172.01M |
| Free Cash Flow (TTM) | 235.36M |
| EPS (TTM) | $3.57 |
| Profit Margin | 15.57% |
| Operating Margin | 26.26% |
| Return on Equity (ROE) | 8.97% |
| Debt to Equity | 1.05 |
| Annual Dividend | $0.00 |
|---|---|
| Dividend Yield | 0.00% |
| Payout Ratio | 0.00% |
| Last Dividend Ex-Date | Sep 27, 2018 |
| Market Cap | 2.34B |
|---|---|
| Shares Outstanding | 47.60M |
| P/E Ratio (TTM) | 13.62 |
| Forward P/E | 17.06 |
| Price to Sales (P/S) | 2.12 |
| Price to Book (P/B) | 1.22 |
| EV/EBITDA | 13.65 |
| 50-Day MA | $49.37 |
|---|---|
| 200-Day MA | $54.96 |
| 1-Year Change | −20.76% |
Source: Market prices and company fundamentals. Data as of Oct 16, 2026. Data sources and methodology
Prestige Consumer Healthcare at a Glance
As of the Oct 16, 2026 close, Prestige Consumer Healthcare (PBH) has a market capitalization of $2.34B. The stock trades at 13.6× trailing earnings, 17.1× forward earnings and 2.1× sales. Over the trailing twelve months it earned $172.01M on revenue of $1.10B (a 15.6% profit margin) and generated $235.36M of free cash flow. Revenue fell 1.4% year over year.
As of its latest reported balance sheet, it holds $89.13M in cash and securities against $2.02B of debt, a net debt position of $1.93B.
Prestige Consumer Healthcare does not currently pay a dividend.
The share price is down 20.8% over the past year. At $49.92 (the Oct 16, 2026 close) it sits within its 52-week range of $42.62 to $71.07, below its 200-day moving average of $54.96.
Based on 3 professional analyst ratings from the past 90 days, the consensus is Buy with an average price target of $72.00, 44.2% above the Oct 16, 2026 close.
Frequently Asked Questions About Prestige Consumer Healthcare
What is the current stock price for PBH?
As of the Oct 16, 2026 close, PBH stock trades at $49.92. The 52-week range is $42.62–$71.07, with a day range of $49.28–$50.27.
What is the P/E ratio for PBH?
As of the Oct 16, 2026 close, Prestige Consumer Healthcare's trailing twelve-month (TTM) P/E ratio is 13.6, meaning investors pay $13.6 for every $1 of annual earnings. The forward P/E is 17.1, reflecting analyst expectations for future earnings. Prestige Consumer Healthcare operates in the Healthcare sector.
Does PBH pay dividends?
Prestige Consumer Healthcare does not currently pay a regular dividend. The company retains its earnings to reinvest in the business. Check the Dividends tab for historical dividend information.
What do analysts recommend for PBH?
Based on ratings from 3 professional analysts over the last 90 days, the consensus for PBH is Buy. The average 12-month price target is $72.00, a 44.2% upside from the Oct 16, 2026 close of $49.92.
What is the market cap of PBH?
As of the Oct 16, 2026 close, Prestige Consumer Healthcare's market capitalization is $2.38B, classifying it as a mid-cap company. Prestige Consumer Healthcare operates in the Healthcare sector within the Drug Manufacturers - Specialty & Generic industry.